Annual Report 2020

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2020 95 The United Laboratories International Holdings Limited Annual Report 2020 13. DIRECTORS’ AND CHIEF EXECUTIVE’S EMOLUMENTS Directors’ and chief executive’s remuneration for the year, disclosed pursuant to the applicable Listing Rules and Hong Kong Companies Ordinance, is as follows: 2020 (a) Executive directors Tsoi Leung Choy Fang Zou Zhu Hoi Shan Wing Hon Siu Chit Yu Ping Xian Hong Su Yan Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 Fees – – – – – – – Other emoluments Salaries and other benefits 3,426 3,417 3,211 1,606 1,606 1,606 14,872 Bonus – – – 720 720 720 2,160 Contributions to retirement benefit schemes (Note) 16 16 16 12 14 (14) 60 Sub-total 3,442 3,433 3,227 2,338 2,340 2,312 17,092 The executive directors’ emoluments shown above were for their services in connection with the management of the affairs of the Company and the Group. (b) Independent non-executive directors Chong Song Fu Peng Oon Ming Xiao Nan Total RMB’000 RMB’000 RMB’000 RMB’000 Fees 214 214 214 642 The independent non-executive directors’ emoluments shown above were for their services as directors of the Company. Total 17,734 Note: During the year ended 31 December 2020, Ms. Zhu Su Yan was eligible for refund on contributions to the social benefit schemes in respect of year 2019.